Defending Rights
Breaking Barriers
Reaching People with HIV Services
Global Aids Update 2019
Review
Drake AL et al. Journal of the International AIDS Society 2019, 22:e25271 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25271/full | https://doi.org/10.1002/jia2.25271
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more
The GHS Index is intended to be a key resource in the face of increasing risks of high-consequence and globally catastrophic biological events and in light of major gaps in international financing for preparedness. These risks are magnified by a rapidly changing and interconnected world; increasing ...political instability; urbanization; climate change; and rapid technology advances that make it easier, cheaper, and faster to create and engineer pathogens.
Key findings from the study of 195 countries:
• Out of a possible 100 points, the average GHS Index score across 195 countries was 40.2.
• The majority of high- and middle-income countries do not score above 50.
• Action is urgently needed to improve countries’ readiness for high-consequence infectious disease outbreaks.
more
UNAIDS | 2016–2021 Strategy
Accessed: 20.11.2019
The report shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work... together, lives are saved, injustices are prevented and dignity is restored.
more
Productive and Inclusive Cities for an Emerging Democratic Republic of Congo
The Government of Malawi, in fulfilling its primary role of protecting the lives of its vulnerable citizens during disasters and reducing their exposure to risk through preparedness, led the development of a National Coronavirus Disease (COVID-19) Preparedness and Response Plan.
Nos enfrentamos a la mayor desaceleración económica de la que se tenga memoria. El sistema humanitario se está preparando para un drástico aumento de los conflictos, la inseguridad alimentaria y la pobreza a medida que las economías se contraen y desaparecen los ingresos por exportaciones, las ...remesas y el turismo.
Los confinamientos y la recesión económica pueden significar una pandemia de hambre para millones de personas.
more
La pandémie du COVID-19 nous fait tous souffrir. Mais ses effets les plus dévastateurs et les plus déstabilisants se feront ressentir dans les pays les plus pauvres du monde. Nous sommes confrontés au plus important ralentissement économique que nous ayons connu de mémoire d’homme. Le systè...me humanitaire se prépare à une forte hausse des conflits, de l’insécurité alimentaire et de la pauvreté avec la contraction de l’économie et la disparition des recettes d’exportation, des envois de fonds et du tourisme. Les confinements et la récession économique pourraient impliquer une pandémie de la faim pour des millions de personnes.
more
Previous pandemics have demonstrated that more people could die from the indirect consequences of an outbreak than from the disease itself. As the fight against the pandemic is pushing millions into poverty and hunger, COVID-19 will likely be no different.
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...require personnel and laboratory infrastructure that are often lacking. An alternative specimen type is dried blood spots (DBS), which can be made without special laboratory processing. DBS are more easily transported than plasma because they can be shipped at ambient temperature as non-hazardous materials using regular mail or courier services.
3rd edition
more
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report... on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019) presents a decade’s worth of data on drug efficacy and surveillance, as well as recommendations to monitor and protect the efficacy of malaria treatment in the decades to come.
more
BMJ Global Health2020;5:e002014. doi:10.1136/bmjgh-2019-002014
Lancet Planet Health 2020; 4: e271–79
Constraints, Technologies, Policies and Processes
Transformation and outlook